Harvard School of Public Health: Omicron's 'Milder' Severity Likely Due to Population Immunity
February 03, 2022
February 03, 2022
BOSTON, Massachusetts, Feb. 3 (TNSJou) -- Harvard University's T.H. Chan School of Public Health issued the following news release:
The SARS-CoV-2 Omicron variant's "milder" outcomes are likely due to more population immunity compared to earlier waves of the pandemic rather than the virus's properties, according to a paper by William Hanage, associate professor of epidemiology and co-director of the Center for Communicable Disease Dynamics at Harvard T.H. Ch . . .
The SARS-CoV-2 Omicron variant's "milder" outcomes are likely due to more population immunity compared to earlier waves of the pandemic rather than the virus's properties, according to a paper by William Hanage, associate professor of epidemiology and co-director of the Center for Communicable Disease Dynamics at Harvard T.H. Ch . . .